Join Dan McCollum and EM clinical pharmacist RJ LaCoursiere as they discuss the use of buprenorphine for the treatment of Opioid Use Disorder.

Who should be considered for treatment with Medication-Assisted Treatment (MAT)?
Why should it be avoided if the patient isn't in acute withdrawal?
What is a DEA X waiver and why should you look into getting waivered?

Free training can be found at https://nhsc.hrsa.gov/loan-repayment/receive-medication-assisted-treatment-training .